Delhi's All India Institute of Medical Sciences (AIIMS) is also planning to start the clinical trials of the indigenous Bharat Biotech's Covid-19 vaccine “Covaxin” on children on Monday, news agency ANI said on Sunday, citing sources.
Until now, AIIMS Patna has started the Paediatric clinical trial of the Covaxin after Bharat Biotech received the Drugs Controller General of India (DCGI) nod to conduct clinical trials on children on May 11. Watch the full report.